Carfilzomib produces OS benefit vs. bortezomib in relapsed, refractory disease March 30, 2017Vol.40 No.03
Health Disparities Study: Minority Women Receive Poorer Care for Cervical Cancer February 28, 2017Vol.40 No.02
Pitt Study Finds Potential Marker of Drug Response in Many Cancer Types February 28, 2017Vol.40 No.02
Immune Responses in Virus-Related Skin Cancer Suggest Immunotherapy Strategy February 28, 2017Vol.40 No.02
